ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2254

Complementary and Alternative Medicine in Rheumatoid Arthritis – Persistently High Use Over the Past Decade Despite Advent of Biologics

Dana DiRenzo1,2, Haiyan Sun3, H. Lester Kirchner3 and Eric D. Newman4, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Internal Medicine, University of Maryland Medical Center, Baltimore, MD, 3Geisinger Center for Health Research, Geisinger Health System, Danville, PA, 4Department of Rheumatology, Geisinger Health System, Danville, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: alternative medicine, Osteoarthritis, quality and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Complementary and Alternative Medicine (CAM) is commonly used when traditional medicine cannot reliably alter the disease.  Over the past decade, rheumatoid arthritis (RA) treatment has improved dramatically whereas osteoarthritis (OA) treatment has not.  Accordingly, CAM use should be trending downward in RA relative to OA.  Previous studies of CAM use by RA and OA patients have been limited by inaccurate diagnosis of arthritis and lack of long term trending.  The purpose of this study was to evaluate the use of CAM in a well-defined population of RA and OA patients now and compared with a similar population 12 years previously.

Methods: 104 OA patients and 102 RA patients attending a Rheumatology clinic twice between May 1, 2011 and June 30, 2012 returned an 84 item questionnaire assessing their CAM use in the past 6 months.  Inclusion criteria were met with ICD-9 codes; patients with other co-existing rheumatologic conditions were excluded.  This survey was compared to survey results previously reported in 2000 assessing CAM use. 

Results: In 2012, most participants were female (OA, 84%; RA, 74%).  RA patients were younger and reported less pain than OA patients (57.9 vs. 70.1 years old, p<0.001; 3.5 vs. 4.9 on a 0-10 cm pain scale, p<0.001).  Only 25% of OA and 20% of RA patients reported that their rheumatologist asked about CAM use.  Likewise, only 30% of OA and 26% of RA patients reported that they told their rheumatologist about their CAM use. 

In 2012, prayer was the most popular form of CAM for both OA and RA patients (63% and 61%) followed by glucosamine/chondroitin, green tea, fish oil, massage, and chiropracty (Figure 1).  Additionally, glucosamine, chondroitin, fish oil, and water therapy were tried more commonly by OA patients than RA patients.

No significant decreases were found overtime in CAM use by RA patients compared with trends observed in OA patients for CAM use overall or by CAM category.  Compared to 2000, RA patients in 2012 reported having tried several forms of CAM for specific treatment of their arthritis more often including cartilage, flaxseed, green tea, and melatonin (p=0.049, 0.049, 0.046, 0.014).  Chiropracty, fish oil, and yoga were also tried more often by RA patients in 2012 (p=0.078, 0.007, 0.008). 

Conclusion: Despite pharmacologic advances for RA compared to OA over the past decade, there was not a decline in the use of CAM among RA patients.  Prayer remains the most common CAM for both OA and RA patients in 2012.  Increased use of certain individual therapies may reflect current cultural/market trends or possible immunologically active properties.  A gap in communication between patient and physician about CAM use was identified, which is concerning due to the undetermined efficacies of the majority of CAM therapies.  This may serve as an opportunity to change current practice and to improve shared medical decision making.

 

Figure 1: Selected CAM Use

OA: 2012 survey (n=104)

RA: 2012 survey (n=102)

p value

Alternative Healing Systems

27.88%

22.55%

0.378

Chiropracty

24.51%

20.00%

0.441

 

 

 

 

Mind, Body & Spirit

65.38%

59.80%

0.408

Meditation

11.76%

14.29%

0.596

Prayer

63.00%

61.22%

0.797

 

 

 

 

Massage & Bodywork

27.88%

24.51%

0.582

Massage

26.73%

24.00%

0.656

 

 

 

 

Diets

43.27%

30.39%

0.056

Fish Oil

36.54%

23.47%

0.043

 

 

 

 

Herbs & Supplements

67.31%

57.84%

0.160

Chondroitin

42.86%

15.84%

<0.001

Glucosamine

50.51%

21.78%

<0.001

Green Tea

33.00%

28.00%

0.443

 

 

 

 

Miscellaneous

14.42%

21.57%

0.182

Copper Bracelets

7.84%

11.88%

0.334

Magnets

9.80%

11.00%

0.781

 

 

 

 

Moving Medicine

42.57%

18.18%

<0.001

Yoga

8.08%

10.20%

0.605

Water Exercise

36.00%

12.24%

<0.001

 


Disclosure:

D. DiRenzo,
None;

H. Sun,
None;

H. L. Kirchner,
None;

E. D. Newman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complementary-and-alternative-medicine-in-rheumatoid-arthritis-persistently-high-use-over-the-past-decade-despite-advent-of-biologics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology